Learn about genetic studies of cognition risks related to Alzheimer's disease in in Mayo Clinic's Precision Medicine in Neurodegeneration Lab led by Nilufer Ertekin-Taner, M.D., Ph.D.

But here's why you likely won't be seeing it in your doctor's office anytime soon.

Taner, M.D., Ph.D., who leads Mayo Clinic's Precision Medicine in Neurodegeneration Lab, studies complex genetic interactions in Alzheimer's disease.

Alzheimer’s disease is one of humanity’s most formidable foes. It affects 10 percent of people over age 65 and kills more people each year than breast cancer and prostate cancer combined. Its effects ...

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

Anyone who’s lost a loved one to Alzheimer's disease may be worried about noticing symptoms in themselves. Alzheimer's takes a terrible toll. It’s the most common cause of dementia — abnormal brain ...

Alzheimer’s disease is a progressive brain disorder and the most common cause of dementia. It’s linked to abnormal protein buildup in the brain, which damages brain cells over time. This leads to ...

More than 7 million Americans currently have Alzheimer’s disease (AD). That’s according to the Alzheimer’s Association. One out of every nine seniors over age 65 will experience some degree of ...

New paper from UC Santa Cruz chemistry lab argues that efforts to develop treatments for Alzheimer's should stop ignoring a ...

Scientists combine advanced proteomics and AI to reveal structural blood protein changes that could help distinguish early Alzheimer’s from mild cognitive impairment. Study: Structural signature of ...

Source: Garrondo, Public domain, via Wikimedia Commons Have you ever heard someone claim that cognitive decline or even dementia is inevitable as we age, and wondered if that doom-and-gloom statement ...